RTW Investments’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

RTW Investments’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-75,400	Closed	-$1.81M	–	81
2022 Q3	$1.81M	Sell	75,400 -5,850	-7%	-$151K	0.04%	82
2022 Q2	$1.61M	Hold	81,250	–	–	0.04%	98
2022 Q1	$2.92M	Hold	81,250	–	–	0.06%	86
2021 Q4	$3.64M	Hold	81,250	–	–	0.05%	101
2021 Q3	$5.79M	Hold	81,250	–	–	0.09%	89
2021 Q2	$10.7M	Hold	81,250	–	–	0.16%	71
2021 Q1	$10.9M	Buy	+81,250	New	+$10.3M	0.17%	68

Other funds holding ASLN

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Waterfront Wealth Overland Park, Kansas $645M AUM 27.59% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

RTW Investments's ASLN Position: Q4 2022 in Review

RTW Investments sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q4 2022, closing a stake of 75,400 shares — an estimated $1.81M sold.

RTW Investments first reported a position in ASLN in Q1 2021 and held it in 7 quarters. The position peaked at $10.9M in Q1 2021. 24 funds tracked by Wall St. Rank hold ASLN as of Q4 2022.

RTW Investments reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q4 2022 after selling out during the quarter.
RTW Investments sold 75,400 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q4 2022, an estimated $1.81M.
RTW Investments first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q1 2021 and held it in 7 quarters.
RTW Investments's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $10.9M in Q1 2021.
24 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q4 2022.

Based on RTW Investments's 13F filing for Q4 2022, filed 14 Feb 2023.